Abstract
Programmed cell death 1 (PD-1) is an inducible immune modulatory receptor. Upon interaction with its ligands B7 homolog 1 (PD-L1) and B7-DC (PD-L2), PD-1 plays important roles in negative regulation of T cell responses to antigen stimulation and maintaining peripheral tolerance. In addition to the inducible expression pattern on conventional T cells, PD-1 is also found on regulatory T cells, follicular T and B cells, and antigen-presenting cells including activated dendritic cells and monocytes. Therefore, PD-1 may have a much broader functionality than expected in negative regulation of multiple arms of immune responses. In addition to cancer therapy, the manipulation of PD-1 and its ligands may hold great promise for therapeutic applications also in autoimmune and infectious diseases.
Original language | English (US) |
---|---|
Pages (from-to) | 262-264 |
Number of pages | 3 |
Journal | Cancer Journal (United States) |
Volume | 20 |
Issue number | 4 |
DOIs | |
State | Published - 2014 |
Externally published | Yes |
Keywords
- cancer therapy
- Programmed cell death 1 (PD-1)
ASJC Scopus subject areas
- Cancer Research
- Oncology
- Medicine(all)